Role of Annexin A2 in Pancreatic Cancer Metastasis
Author Information
Author(s): Zheng Lei, Foley Kelly, Huang Lanqing, Leubner Ashley, Mo Guanglan, Olino Kelly, Edil Barish H., Mizuma Masamichi, Sharma Rajni, Le Dung T., Anders Robert A., Illei Peter B., Van Eyk Jennifer E., Maitra Anirban, Laheru Daniel, Jaffee Elizabeth M.
Primary Institution: Johns Hopkins University School of Medicine
Hypothesis
Is Annexin A2 a key factor in the invasion and metastasis of pancreatic cancer?
Conclusion
Annexin A2 is essential for the invasion and metastasis of pancreatic cancer, and targeting it may provide new therapeutic options.
Supporting Evidence
- Annexin A2 was identified as a new molecule that promotes pancreatic cancer invasion and metastasis.
- Knockdown of Annexin A2 expression inhibited the in vitro invasion of pancreatic cancer cells.
- In vivo studies showed that targeting Annexin A2 prolonged survival in mouse models of pancreatic cancer.
Takeaway
This study found that a protein called Annexin A2 helps pancreatic cancer cells spread, and blocking it could help treat the disease.
Methodology
The study used immunohistochemistry, RNA interference, and mouse models to investigate the role of Annexin A2 in pancreatic cancer.
Potential Biases
Potential bias in patient selection and the interpretation of immunological responses.
Limitations
The study primarily focused on a specific protein and its mechanisms, which may not encompass all factors involved in pancreatic cancer metastasis.
Participant Demographics
Patients with pancreatic ductal adenocarcinoma who participated in a phase II clinical trial.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website